|
Re: news from ASCO-- some joyous, some a downer--may set things back a bit
I agree - I'm lucky to be in this situation "post-Herceptin and Perjeta" - some 10 or so years ago, it was even "more scarier"... However, I find it daunting when my Onco tells me to all but stop looking at what's currently going on in research, since she feels it's unlikely I will have enough time to profit from it. Add to that that the processes seems get longer and less focused, it's bitter pill when you don't have time to loose...
Oh well, I'm still at the beginning of the journey, and yes, I currently put my hopes in first line treatment lasting for a looooong time...
__________________
Annette
----------------------------------------
03/2014: Diagnosed with ER/PR-, HER2+++ MBC (bone mets, oligometastatic)
04/2014: Started 6 cycles of "PHD" (Perjeta, Herceptin, Docetaxol)
07/2014: Finished 6 cycles of PHD; restaging; 2 bone mets are sclerotic - looks like Herceptin and Perjeta is working
10/2014: STABLE!
01/2015: STABLE!
04/2015: STABLE!
08/2015: STABLE!
12/2015: BRAIN METS. BODY STABLE.
|
Threaded Mode